Aug 6
NHNKF · Nihon Kohden Corporation
Market Cap
$1.57B
Shares
159.97M
Volume · Sep 21
250
Avg daily vol (3 sessions)
233
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$9.80
Open$9.80
Day$9.80–9.80
Available close range$9.60–9.82
Avg vol available · 16d848
Short int958K · 0.6% of shares
Short vol100%
Last earningsNov 10, 2026
DataOct 2020–Sep 2026
The closing range uses available history since Aug 6, 2026; less than a full year is stored.
Up next
Feb 4, 2027
Est · unconfirmed
· in 12 wks
call held Aug 6, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
+4.3%
Year over year
Operating margin
7.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
2.1%
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.6%
Latest settlement
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Buy
Momentum
Limited
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.72
Technical
price trend
50 / 200-day cross
No cross
RSI (14)
24
oversold
52-week position
91%
near high
Momentum
relative strength
Not enough data for a confident read.
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.60% of shares out · ▲ +2.2% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
35
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
272%
annualized · 1-yr
Max drawdown
−70%
past year
ATR
26.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Aug 6, 2026
as of Sep. 30, 2026
Transfer of operations for Abbott products
95%
FY2026
Operating margin
10.1%
Overseas sales ratio
42.6%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
RSI (14)
24
Neutral
52-week position
91%
Bullish
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.60% of shares out · ▲ +2.2% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its available closing range
Range low $10
Now $10 · 91%
Range high $10
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NHNKF
this stock
Nihon Kohden Corporation
|
$1.57B | — | — | — | 0.6% |
|
ABT
Abbott Laboratories
|
$185.75B | -14.4% | +5.7% | 40.0 | 1.1% |
|
MDT
Medtronic plc
|
$129.18B | +5.1% | +8.4% | 24.9 | 1.8% |
|
SYK
Stryker Corp
|
$118.92B | -11.1% | +11.2% | 33.3 | 1.7% |
|
BSX
Boston Scientific Corp
|
$64.07B | -53.6% | +12.5% | 18.7 | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NHNKF | -62.6% | — | — | -0.2% | -35.0% |
| SPY | +1.7% | +1.0% | +22.4% | +0.8% | +13.4% |
| vs SPY | -64.2% | — | — | -1.0% | -48.4% |
Capital returns
Latest dividend
$0.101
/ share · ex Sep 29, 2026
Paid (TTM)
$0.2019
/ share · 2 payouts
Dividend yield (TTM, derived)
— · history filling in
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.